Affiliation:
1. School of Molecular Biosciences, College of Veterinary Medicine, Washington State University, Pullman, Washington, USA
2. Paul G. Allen School for Global Health, College of Veterinary Medicine, Washington State University, Pullman, Washington, USA
Abstract
ABSTRACT
Coxiella burnetii
is an obligate intracellular bacteria that causes the global zoonotic disease Q Fever. Treatment options for chronic infection are limited, and the development of novel therapeutic strategies requires a greater understanding of how
C. burnetii
interacts with immune signaling. Cell death responses are known to be manipulated by
C. burnetii
, but the role of caspase-8, a central regulator of multiple cell death pathways, has not been investigated. In this research, we studied bacterial manipulation of caspase-8 signaling and the significance of caspase-8 to
C. burnetii
infection, examining bacterial replication, cell death induction, and cytokine signaling. We measured caspase, RIPK, and MLKL activation in
C. burnetii
-infected tumor necrosis factor alpha (TNFα)/cycloheximide-treated THP-1 macrophage-like cells and TNFα/ZVAD-treated L929 cells to assess apoptosis and necroptosis signaling. Additionally, we measured
C. burnetii
replication, cell death, and TNFα induction over 12 days in RIPK1-kinase-dead, RIPK3-kinase-dead, or RIPK3-kinase-dead-caspase-8
−/−
bone marrow-derived macrophages (BMDMs) to understand the significance of caspase-8 and RIPK1/3 during infection. We found that caspase-8 is inhibited by
C. burnetii
, coinciding with inhibition of apoptosis and increased susceptibility to necroptosis. Furthermore,
C. burnetii
replication was increased in BMDMs lacking caspase-8, but not in those lacking RIPK1/3 kinase activity, corresponding with decreased TNFα production and reduced cell death. As TNFα is associated with the control of
C. burnetii
, this lack of a TNFα response may allow for the unchecked bacterial growth we saw in caspase-8
−/−
BMDMs. This research identifies and explores caspase-8 as a key regulator of
C. burnetii
infection, opening novel therapeutic doors.
Funder
HHS | NIH | National Institute of Allergy and Infectious Diseases
Poncin Fellowship
Publisher
American Society for Microbiology